(A) Comparison of suppressive activity between tTreg and iTreg. CFSE (carboxy fluoroscein succinimidyl Eester) -labeled OT-II T cells were stimulated with OVA-pulsed DC, then Foxp3-GFP+ iTregs and …
The suppression activity, AFM force of iTreg and nTreg, and calcium oscillation during iTreg induction.
(A) QPCR for Ryr2 mRNA expression in iTregs, tTregs, and Tconvs. n = 3, N = 4. (B) The effect of Ryr2 expression on iTreg induction. Naive Tconv cells were sorted from Ryr2 fl/fl; CD4 cre mice and …
(A) Comparison of Treg stability between tTregs and iTregs. iTregs and tTregs were sorted and restimulated with anti-CD3 and anti-CD28 antibodies. Cells were harvested after 2-day restimulation and …
Treg stability, early store-operated calcium entry (SOCE) signal, long-term SOCE signal in iTreg and nTreg.
Original imaging data of long-term store-operated calcium entry (SOCE) signal in Tconv, nTreg, and iTreg, related to Figure 2C.
Original western data of NFAT nuclear translocation in Tconv, nTreg, and iTreg, related to Figure 2D.
(A) Calcium oscillation were recorded in steady state and after anti-CD3 and anti-CD28 activation. Tconv cells were loaded with Fluo-4 AM, and left in steady state without anti-CD3 and anti-CD28 …
Original western data of NFAT nuclear translocation upon early activation in Tconv, nTreg, and iTreg, related to Figure 2—figure supplement 1D.
(A) Principal component analysis (PCA) visualization of transcriptional profiles of Tconvs, tTregs, and iTregs with or without TCR stimulation. Color indicates cell types. (B) PCA visualization of …
(A) Left, heatmap showing the top genes that positively contribute to PC1. Right, heatmap showing the top genes that negatively contribute to PC1. As shown, genes contributing positively to PC1 …
(A) Impact of calcium signal and NFAT on iTreg stability. Sorted Foxp3-GFP+ iTregs were rested for 1 day, then restimulated by anti-CD3 and CD28 in the presence of cyclosporine A (CsA) and CM-4620. …
iTreg stability, QPCR of related gene expression upon activation after CsA and CM-4620 blockade.
(A) Stability of iTreg treated with CM-4620, cyclosporine A (CsA), and BTP-2 upon restimulation. iTregs were restimulated by anti-CD3 and CD28 in the presence of CsA, CM-4620, and BTP-2. Percentages …
(A) Model of CUT&Tag experiments to capture the binding sites of NFATc1. (B) The number of NFAT Cut&Tag peaks in mock control, resting iTregs, and restimulated iTregs. (C) Normalized counts of …
IL-21 secretion in tTreg and iTreg upon activation.
(A) Sorted Foxp3-RFP+ naive Tconvs were induced into iTregs in the presence of IL-2 and TGF-β for 4 days, on the second and third days, iTreg cells were infected with retrovirus packaging with …
(A) Manipulation of SOCE signal by dominant negative ORAI (DN-ORAI). SOCE was recorded in DN-ORAI iTreg cells loaded with Fura-Red by flow cytometry, TG was added after 1 min to induce ER depletion, …
Store-operated calcium entry (SOCE) signal, iTreg stability in vitro and in vivo after over-expression DN-ORAI.
(A) Line plots (top) and heatmaps (bottom) of activation regions in anti-CD3, anti-CD28, IL-2, and TGF-β-induced iTregs, treated with retinoic acid, rapamycin, vitamin C, removal of CD28, and …
Sorted Foxp3-GFP+ iTregs were rested for 1d, and then rested or restimulated in the presence of TGF-β for 2 d. Percentages of Foxp3+ cells were analyzed by intracellular staining of Foxp3 after 2 d.
Sorted Foxp3-GFP+ iTregs were rested for 1d, then restimulated by anti-CD3 and CD28 in the presence of listed inhibitors. Percentages of Foxp3+ cells were analyzed by intracellular staining after 2d …
Genome track visualization of NFAT binding profiles and H3K4me3 profiles in Foxp3 CNS3 locus in two batches of dataset.
Human naïve CD4 cells from PBMC were subjected to a two-week induction process to generate human iTreg. Subsequently, human iTreg were restimulated for 2 days with dynabeads followed by 2 days of …
PCA visualization of chromatin accessibility profiles of different cell types. Color indicates cell type.
WT-ORAI/DN-ORAI-GFP+-transfected CD45.2+ Foxp3-RFP+ OT-II iTregs were transferred i.v. into CD45.1 mice. Recipients were left or immunized with OVA323-339 in Alum adjuvant. On day 5, mLN were …
After 4 days, CFSE dilution were analyzed. Left, Representative histograms of CFSE in divided Tconvs. Right, graph for the percentage of divided Tconvs.
Genomic track showing chromatin accessibility of Irf4, Atf3, Lta, Tnfsf8, Tnfsf4, Tnsfsf14, Il12rb2, Il9, Gzmc in activated Tconv and iTreg.
Sorted Foxp3-GFP+ iTregs were rested for 1d, then restimulated by anti-CD3 and CD28 in the presence of CsA or CM-4620. After 2d restimulation, live cell percentage were analyzed by staining of …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C57BL6/J | Jackson Laboratory | Strain #:000664 from Jackson Laboratory | |
Strain, strain background (Mus musculus) | Foxp3-GFP (B6.Cg-Foxp3tm2Tch/J) | Hai Qi of School of Medicine, Tsinghua University | Strain #:006772 from Jackson Laboratory | |
Strain, strain background (Mus musculus) | Foxp3-RFP | Zhou Xuyu of Institute of Microbiology, Chinese Academy of Sciences | Foxp3-RFP | |
Strain, strain background (Mus musculus) | CD45.1 | Jackson Laboratory | Strain #:002014 from Jackson Laboratory | |
Strain, strain background (Mus musculus) | OT-II | Hai Qi of School of Medicine, Tsinghua University | Strain #:004194 from Jackson Laboratory | |
Antibody | Ultra-LEAF Purified anti-mouse CD3ε Antibody, Armenian Hamster monoclonal | Biolegend | 100340 | 0.5 μg/ml |
Antibody | Ultra-LEAF Purified anti-mouse CD28 Antibody, Syrian Hamster monoclonal | Biolegend | 102116 | 1 μg/ml |
Antibody | NFATc1 Antibody (7A6), mouse monoclonal | Santa Cruz | sc-7294 | 1:2000 |
Antibody | NFATc2 Antibody (4G6-G5), mouse monoclonal | Santa Cruz | sc-7296 | 1:2000 |
Antibody | Lamin A/C (4C11) Mouse mAb | CST | 4777 | 1:2000 |
Antibody | β-Actin (13E5) Rabbit mAb | CST | 4970 | 1:1000 |
Antibody | GAPDH (D4C6R) Mouse mAb | CST | 97166 | 1:1000 |
Antibody | Monoclonal ANTI-FLAG M2 antibody produced in mouse | Sigma | F1804 | 1:50 |
Antibody | Goat Anti-Mouse IgG Secondary Antibody, monoclonal | Sino Biological | SSA021 | 1:50 |
Antibody | Histone H3 (D2B12) XP Rabbit mAb (ChIP Formulated) | CST | 4620 | 1:50 |
Antibody | Anti-Histone H3 (tri methyl K4) antibody - ChIP Grade, Rabbit polyclonal | Abcam | ab8580 | 1:50 |
Antibody | Goat Anti-Rabbit IgG Secondary Antibody, monoclonal | Sino Biological | SSA018 | 1:50 |
Antibody | Biotin anti-mouse CD3ε Antibody, Armenian Hamster monoclonal | Biolegend | 100303 | 0.5 μg/ml |
Antibody | FOXP3 Monoclonal Antibody (150D/E4), PE, mouse monoclonal | eBioscience | 12-4774-42 | 1:500 |
Antibody | FOXP3 Monoclonal Antibody (150D/E4), Alexa Fluor 488, mouse monoclonal | eBioscience | 53-4774-41 | 1:500 |
Antibody | CD4 Monoclonal Antibody (GK1.5), APC, rat monoclonal | eBioscience | 17-0041-82 | 1:500 |
Antibody | CD25 Monoclonal Antibody (PC61.5), PE, rat monoclonal | eBioscience | 12-0251-82 | 1:500 |
Antibody | CD44 Monoclonal Antibody (IM7), APC, rat monoclonal | eBioscience | 17-0441-83 | 1:500 |
Antibody | PE anti-mouse CD62L, rat monoclonal | Biolegend | 104408 | 1:500 |
Peptide, recombinant protein | Recombinant Human TGF-beta 1 Protein | R&D | 240-B-010 | |
Peptide, recombinant protein | Recombinant Human IL-2 | R&D | 202-IL | |
Peptide, recombinant protein | Purified Streptavidin | Biolegend | 405150 | |
Commercial assay, kit | LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, for 405 nm excitation | Invitrogen | L34965 | |
Commercial assay, kit | Propidium Iodide | Beyotime | C1062M-3 | |
Commercial assay, kit | Mouse CD4+ T Cell Isolation Kit | Stem cell | 19852 | |
Commercial assay, kit | Mouse CD25 Treg Cell positive selection Kit | Stem cell | 18782 | |
Commercial assay, kit | Foxp3/Transcription Factor Staining Buffer Set | eBioscience | 00-5523-00 | |
Commercial assay, kit | NE-PER Nuclear and Cytoplasmic Extraction Reagents | Thermo | 78835 | |
Commercial assay, kit | TruePrep DNA Library Prep Kit V2 for Illumina | Vazyme | TD501 | |
Commercial assay, kit | Hyperactive Universal CUT&Tag Assay Kit for Illumina | Vazyme | TD903 | |
Commercial assay, kit | TruePrep Index Kit V2 for Illumina | Vazyme | TD202 | |
Commercial assay, kit | VAHTS DNA Clean Beads | Vazyme | N411 | |
Commercial assay, kit | Mouse IL-21 Uncoated ELISA | Invitrogen | 88–8210 | |
Chemical compound, drug | Cyclosporin A | MCE | HY-B0579 | |
Chemical compound, drug | CM-4620 | MCE | HY-101942 | |
Chemical compound, drug | Thapsigargin | Invitrogen | T7459 | |
Chemical compound, drug | Ionomycin | beyotime | S1672 | |
Chemical compound, drug | Caffeine | Aladdin | C106953 | |
Chemical compound, drug | 4-CMC | Sigma | C55402 | |
Chemical compound, drug | Fluo-4, AM, cell permeant | Thermo | F14201 | |
Chemical compound, drug | Cal RedTM R525/650 AM | AAT Bioquest | 20591 | |
Chemical compound, drug | Indo-1 AM | BD | 565879 | |
Chemical compound, drug | Pluronic F-127 | Sigma | P2443 | |
Chemical compound, drug | CellTak 1 MG WI, 1/CS | BD | 354240 | |
Chemical compound, drug | Hanks’ Solution | Coolaber | SL6080 | |
Chemical compound, drug | HBSS, 10× (without Calcium) | Macgene | CC016 | |
Chemical compound, drug | Imject Alum | Thermo | 77161 | |
Chemical compound, drug | OVA Peptide (323-339) | GenScript | RP10610-1 | |
Chemical compound, drug | OVA | Sigma | A5503 | |
Chemical compound, drug | Cell Trace CFSE | Thermo | C34554 | |
Chemical compound, drug | Retinoic Acid | Sigma | R2625 | |
Chemical compound, drug | InSolution Rapamycin | Sigma | 553211 | |
Chemical compound, drug | L-Ascorbic acid (Vitamin C) | Sigma | A4403 | |
Chemical compound, drug | AS2863619 | MCE | HY-126675A | |
Chemical compound, drug | BAY 11-7082 | MCE | HY-13453 | |
Chemical compound, drug | SP600125 | MCE | HY-12041 | |
Chemical compound, drug | T-5224 | MCE | HY-12270 | |
Software, algorithm | FlowJo | FlowJo LLC | ||
Software, algorithm | Prism | GraphPad | ||
Software, algorithm | IGV | Broad Institute | ||
Software, algorithm | Imaris | Andor | ||
Software, algorithm | R | R studio | ||
Software, algorithm | JPK Data Processing | JPK |